Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 351-400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06487481
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
PHASE1Recruiting
32 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2040
5 conditions1 sponsor1 location
NCT06876142
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
54 participants
Started: Oct 28, 2025 · Completed: Jan 1, 2033
2 conditions1 sponsor1 location
NCT06860607
Environment and Alcohol: A Pilot Study
PHASE1Recruiting
44 participants
Started: Oct 28, 2025 · Completed: Mar 1, 2028
1 condition1 sponsor1 location
NCT06707207
Predicting Future Errors During Skill Performance
N/ARecruiting
40 participants
Started: Oct 28, 2025 · Completed: Oct 1, 2029
1 condition1 sponsor1 location
NCT05621291
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
NARecruiting
60 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor8 locations
NCT06561828
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
EARLY_PHASE1Recruiting
600 participants
Started: Oct 28, 2025 · Completed: Nov 2, 2044
1 condition1 sponsor1 location
NCT06856226
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
N/ARecruiting
88 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2028
3 conditions1 sponsor1 location
NCT06664814
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
PHASE2Recruiting
30 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT06904066
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
PHASE1Recruiting
86 participants
Started: Oct 28, 2025 · Completed: Apr 30, 2029
11 conditions1 sponsor1 location
NCT06052631
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
N/ARecruiting
16 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05657405
Observational Study of Advanced Data Analytics in Genetic Conditions
N/ARecruiting
1,250 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT06577454
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
NARecruiting
60 participants
Started: Oct 28, 2025 · Completed: Aug 6, 2027
2 conditions1 sponsor1 location
NCT06923072
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
PHASE2Recruiting
12 participants
Started: Oct 28, 2025 · Completed: Dec 15, 2030
4 conditions1 sponsor1 location
NCT06948110
Deciphering the Genetic Architecture of Autoimmune Diseases
N/ARecruiting
300 participants
Started: Oct 28, 2025 · Completed: Apr 22, 2030
1 condition1 sponsor2 locations
NCT07169630
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
PHASE1Recruiting
90 participants
Started: Oct 28, 2025 · Completed: Apr 11, 2030
3 conditions1 sponsor1 location
NCT07204977
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
PHASE1Recruiting
30 participants
Started: Oct 28, 2025 · Completed: Sep 30, 2028
2 conditions1 sponsor1 location
NCT07218796
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
PHASE3Recruiting
400 participants
Started: Oct 28, 2025 · Completed: May 31, 2031
3 conditions1 sponsor1 location
NCT07091422
A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
NARecruiting
20 participants
Started: Oct 27, 2025 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT06731894
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
PHASE2Recruiting
120 participants
Started: Oct 27, 2025 · Completed: Jan 7, 2028
3 conditions2 sponsors2 locations
NCT07117695
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
NARecruiting
150 participants
Started: Oct 27, 2025 · Completed: Jun 27, 2027
3 conditions2 sponsors1 location
NCT07013357
Community Discussions and Social Participation
NARecruiting
200 participants
Started: Oct 27, 2025 · Completed: Dec 15, 2025
3 conditions1 sponsor1 location
NCT06670287
The Use of Multiple Sensors to Track Sleep in Nightshift Workers
NARecruiting
100 participants
Started: Oct 27, 2025 · Completed: Jan 30, 2030
2 conditions2 sponsors1 location
NCT07176273
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
NARecruiting
302 participants
Started: Oct 27, 2025 · Completed: Aug 14, 2028
2 conditions2 sponsors4 locations
NCT07170150
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3Recruiting
800 participants
Started: Oct 27, 2025 · Completed: Nov 7, 2028
1 condition1 sponsor6 locations
NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
PHASE3Recruiting
366 participants
Started: Oct 25, 2025 · Completed: Aug 12, 2034
1 condition1 sponsor92 locations
NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
PHASE3Recruiting
11,000 participants
Started: Oct 24, 2025 · Completed: Oct 29, 2030
3 conditions2 sponsors30 locations
NCT07210320
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
PHASE1Recruiting
30 participants
Started: Oct 24, 2025 · Completed: Mar 31, 2026
2 conditions2 sponsors1 location
NCT06893341
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
NARecruiting
20 participants
Started: Oct 23, 2025 · Completed: Apr 1, 2026
3 conditions1 sponsor1 location
NCT06891885
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 23, 2025 · Completed: Oct 31, 2032
1 condition1 sponsor1 location
NCT07203196
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
NARecruiting
16 participants
Started: Oct 22, 2025 · Completed: Apr 1, 2026
5 conditions2 sponsors1 location
NCT07179484
To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma
N/ARecruiting
20 participants
Started: Oct 22, 2025 · Completed: Sep 1, 2028
1 condition1 sponsor1 location
NCT07153939
Pivotal Study of the Velocity™ pAVF System
NARecruiting
126 participants
Started: Oct 21, 2025 · Completed: Sep 30, 2030
4 conditions1 sponsor2 locations
NCT07217561
"Testing Doula Link, a Multi-Component Intervention to Improve Perinatal Mental Health"
NARecruiting
90 participants
Started: Oct 21, 2025 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT07114822
HOPE Intervention for Fitness
NARecruiting
120 participants
Started: Oct 21, 2025 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT06845319
Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients
PHASE2Recruiting
43 participants
Started: Oct 20, 2025 · Completed: Oct 20, 2028
1 condition1 sponsor1 location
NCT07218458
A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals
NARecruiting
40 participants
Started: Oct 20, 2025 · Completed: Jun 1, 2026
2 conditions1 sponsor4 locations
NCT07055269
Liver Metabolic Functions in Patients With Citrin Deficiency and Healthy Subjects
NARecruiting
20 participants
Started: Oct 20, 2025 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT07134257
Smart Crutch Tips for Guided Weight-Bearing in Patients Recovering From Extra-Articular Proximal Tibia Fractures
NARecruiting
30 participants
Started: Oct 20, 2025 · Completed: Aug 1, 2026
3 conditions1 sponsor11 locations
NCT07157345
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
PHASE1Recruiting
12 participants
Started: Oct 20, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT07211048
Anti CD19 Gene Therapy for B-cell Lymphoma
NARecruiting
18 participants
Started: Oct 20, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT07092579
Smart Crutch Tips for Guided Weight-Bearing in Patients Recovering From Tibial Shaft Fractures
NARecruiting
30 participants
Started: Oct 20, 2025 · Completed: Dec 15, 2026
2 conditions1 sponsor12 locations
NCT07219758
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
NARecruiting
20 participants
Started: Oct 18, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06675136
Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases
PHASE1Recruiting
30 participants
Started: Oct 17, 2025 · Completed: Jan 14, 2029
3 conditions2 sponsors1 location
NCT07111468
Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
PHASE3Recruiting
279 participants
Started: Oct 17, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor11 locations
NCT06512675
Effects of an Exercise Program on Reaction Time and Mouse Accuracy in Recreational Video Game Players
NARecruiting
15 participants
Started: Oct 17, 2025 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06922617
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
NARecruiting
240 participants
Started: Oct 17, 2025 · Completed: Sep 1, 2028
2 conditions2 sponsors3 locations
NCT07143357
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
NARecruiting
84 participants
Started: Oct 17, 2025 · Completed: Jul 31, 2028
8 conditions2 sponsors1 location
NCT07184983
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
NARecruiting
46 participants
Started: Oct 17, 2025 · Completed: Nov 1, 2027
1 condition2 sponsors1 location
NCT07219849
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
PHASE2Recruiting
164 participants
Started: Oct 17, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04843852
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
PHASE1Recruiting
10 participants
Started: Oct 16, 2025 · Completed: Apr 1, 2027
2 conditions1 sponsor1 location